The 13 states where Medicaid covers GLP-1 drugs for obesity are California, Kansas, Minnesota, Wisconsin, Michigan, Mississippi, Pennsylvania, Virginia, North Carolina, Massachusetts, New Hampshire, Delaware and Rhode Island
Data extraction and synthesis were performed iteratively, with emphasis on clinical relevance and perioperative applicability
It was removed in April of 2025 when the FDA declared the shortage was over
While this is uncommon, it underscores the critical importance of maintaining hydration during treatment
Is there a mechanism behind it
In society today, there is a similar goal for both men and women: to be smaller and have a snatched waist or a more muscular body